Polymorphisms in thrombophilic genes are associated with deep venous thromboembolism in an Iranian population
- PMID: 25606434
- PMCID: PMC4287852
- DOI: 10.1016/j.mgene.2014.06.004
Polymorphisms in thrombophilic genes are associated with deep venous thromboembolism in an Iranian population
Abstract
It has been revealed that the inherited thrombophilia increases the risk of thrombosis in the venous system. To study the association of factor V G1691A, factor V HR2 (4070A/G), prothrombin G20210A, and PAI-1 (- 675 I/D, 5G/4G) polymorphisms with deep venous thromboembolism (DVT), these polymorphisms were investigated. A total of 193 patients who presented clinical symptoms of deep venous thromboembolism including 103 men and 90 women, and 500 healthy individuals without both personal and family histories of thromboembolic disorders including 275 men and 225 women were recruited into the study. Genotyping was carried out using the amplification refractory mutation system-polymerase chain reaction (ARMS-PCR) technique. Our results showed that the genotype distribution for FV (G1691A and A4070G) and PAI-1 4G/5G polymorphisms in DVT patients were significantly higher than healthy control (P < 0.05). Also, the mutant allele frequencies for all studied polymorphisms differed significantly between the case and control groups (P < 0.05). We concluded that the prevalence of FV (G1691A and A4070G) and PAI-1 4G/5G polymorphisms increased the risk of DVT occurrence in subjects. These findings provide additional evidence to support the hypothesis that thrombophilic gene polymorphisms are involved in vascular thromboembolism.
Keywords: Deep venous thromboembolism; Inherited thrombophilia; Thrombophilic gene polymorphisms.
Similar articles
-
Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion.Ophthalmic Genet. 2017 Sep-Oct;38(5):413-417. doi: 10.1080/13816810.2016.1244694. Epub 2017 Jan 13. Ophthalmic Genet. 2017. PMID: 28085526
-
Prevalence of thrombophilic gene polymorphisms in an azari population of iran.Hematol Rep. 2014 Apr 22;6(2):5321. doi: 10.4081/hr.2014.5321. eCollection 2014 Apr 22. Hematol Rep. 2014. PMID: 25013715 Free PMC article.
-
[Prevalence of thrombophilic mutations of FV Leiden, prothrombin G20210A and PAl-1 4G/5G and their combinations in a group of 1450 healthy middle-aged individuals in the Prague and Central Bohemian regions (results of FRET real-time PCR assay)].Cas Lek Cesk. 2012;151(2):76-82. Cas Lek Cesk. 2012. PMID: 22515013 Czech.
-
Comparison of thrombophilic gene mutations among patients experiencing recurrent miscarriage and deep vein thrombosis.Am J Reprod Immunol. 2008 Nov;60(5):426-31. doi: 10.1111/j.1600-0897.2008.00640.x. Am J Reprod Immunol. 2008. PMID: 18803625
-
Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism - a meta-analysis and systematic review.Vasa. 2020 Mar;49(2):141-146. doi: 10.1024/0301-1526/a000839. Epub 2020 Jan 10. Vasa. 2020. PMID: 31920171
Cited by
-
The Impact of MTHFR 1298 A > C and 677 C > T Gene Polymorphisms as Susceptibility Risk Factors in Cervical Intraepithelial Neoplasia Related to HPV and Sexually Transmitted Infections.J Obstet Gynaecol India. 2020 Dec;70(6):503-509. doi: 10.1007/s13224-020-01363-z. Epub 2020 Aug 24. J Obstet Gynaecol India. 2020. PMID: 33406167 Free PMC article.
-
Correlation Between PAI-1 Gene 4G/5G Polymorphism and the Risk of Thrombosis in Ph Chromosome-Negative Myeloproliferative Neoplasms.Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620935207. doi: 10.1177/1076029620935207. Clin Appl Thromb Hemost. 2020. PMID: 32683889 Free PMC article.
-
Plasminogen Activator Inhibitor-1 4G/5G Promoter Polymorphism in Indian Patients with Deep Vein Thrombosis.Indian J Hematol Blood Transfus. 2024 Apr;40(2):331-334. doi: 10.1007/s12288-023-01660-3. Epub 2023 May 8. Indian J Hematol Blood Transfus. 2024. PMID: 38708166 Free PMC article.
-
Molecular Analysis of Prothrombotic Gene Variants in Venous Thrombosis: A Potential Role for Sex and Thrombotic Localization.J Clin Med. 2020 Apr 2;9(4):1008. doi: 10.3390/jcm9041008. J Clin Med. 2020. PMID: 32252449 Free PMC article.
-
Coagulation factor V gene 1691G>A polymorphism as an indicator for risk and prognosis of lower extremity deep venous thrombosis in Chinese Han population.Medicine (Baltimore). 2018 Jun;97(22):e10885. doi: 10.1097/MD.0000000000010885. Medicine (Baltimore). 2018. PMID: 29851809 Free PMC article.
References
-
- Akar N., Yilmaz E., Akar E., Avcu F., Yalcin A., Cin S. Effect of plasminogen activator inhibitor-1 4G/5G polymorphism in Turkish deep vein thrombotic patients with and without FV1691 G-A. Thromb. Res. 2000;97(4):227–230. (Feb 15, PubMed PMID: 10674409. Epub 2000/02/16. eng) - PubMed
-
- Alhenc-Gelas M., Nicaud V., Gandrille S., van Dreden P., Amiral J., Aubry M.L. The factor V gene A4070G mutation and the risk of venous thrombosis. Thromb. Haemost. 1999;81(2):193–197. (Feb, PubMed PMID: 10063990. Epub 1999/03/04. eng) - PubMed
-
- Benson J.M., Ellingsen D., El-Jamil M., Jenkins M., Miller C.H., Dilley A. Factor V Leiden and factor V R2 allele: high-throughput analysis and association with venous thromboembolism. Thromb. Haemost. 2001;86(5):1188–1192. (Nov, PubMed PMID: 11816705. Epub 2002/01/31. eng) - PubMed
-
- Bouaziz-Borgi L., Almawi W.Y., Mtiraoui N., Nsiri B., Keleshian S.H., Kreidy R. Distinct association of factor V-Leiden and prothrombin G20210A mutations with deep venous thrombosis in Tunisia and Lebanon. Am. J. Hematol. 2006;81(8):641–643. (Aug, PubMed PMID: 16823828. Epub 2006/07/11. eng) - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous